Why Side Effects Dominate the TRT Conversation

Search for “TRT side effects” and you will find headlines designed to scare you – heart attacks, strokes, prostate cancer, “roid rage.” The internet is extremely good at turning manageable clinical nuances into existential threats.

Here is the reality: testosterone replacement therapy, like any medical treatment, carries potential side effects. Some are genuine clinical concerns that require monitoring. Others are exaggerated, misunderstood, or based on outdated research that has since been contradicted by stronger evidence. And many of the most feared risks can be effectively managed, or avoided entirely – with proper medical oversight.

This guide does not minimize risks. It does not dismiss them. What it does is separate each concern into what the evidence actually says, what is overstated, and what responsible monitoring looks like. If you are considering TRT – or already on it and wondering whether something you read online should worry you, this is the article to read.

Before diving into side effects, make sure you understand what TRT is and how it works. And if you are still at the stage of figuring out whether you actually need it, our article on the 12 signs of low testosterone is a better starting point.

The TRAVERSE Trial: The Study That Changed the Safety Conversation

For years, the biggest concern around TRT was cardiovascular safety. Two observational studies published in 2013–2014 suggested that testosterone therapy might increase the risk of heart attacks and strokes. The FDA responded by requiring a warning label on all testosterone products in 2015.

Then came the TRAVERSE trial, published in the New England Journal of Medicine in 2023. This was the largest randomized, double-blind, placebo-controlled trial ever conducted on TRT safety – enrolling over 5,200 men aged 45–80, all with pre-existing cardiovascular disease or elevated cardiovascular risk, and all with confirmed hypogonadism.

The result: testosterone therapy did not increase the incidence of major adverse cardiovascular events (MACE) compared to placebo. The hazard ratio was 0.96 (95% CI, 0.78–1.17) – essentially no difference.

This was a landmark moment for the field. It did not prove TRT is without any cardiovascular influence – but it definitively showed that the treatment is not the cardiac time bomb it was once feared to be, even in a high-risk population. The earlier observational studies that triggered the FDA warning had significant methodological limitations that the TRAVERSE trial was specifically designed to address.

Real Side Effects: What the Evidence Supports

With the cardiovascular myth properly contextualized, let us walk through the side effects that are genuinely supported by clinical evidence – and what each one actually means for patients.

1. Polycythemia (Elevated Red Blood Cell Count)

The concern: Testosterone stimulates erythropoiesis – the production of red blood cells. In some patients, this pushes hematocrit (the percentage of blood volume occupied by red blood cells) above the safe range, typically defined as above 54%. Elevated hematocrit increases blood viscosity, which theoretically raises the risk of blood clots, stroke, and other thromboembolic events.

How common: This is the single most common laboratory abnormality seen with TRT. The safety monitoring guidelines published by Morgentaler et al. (2016) in Mayo Clinic Proceedings estimate that polycythemia occurs in approximately 5–20% of men on TRT, depending on the delivery method. Injectable testosterone is more likely to cause polycythemia than topical formulations because of the higher peak levels achieved after each injection – though this risk is significantly reduced with more frequent, smaller-dose injection protocols.

How it is managed: This is precisely why regular blood work is non-negotiable on TRT. Hematocrit is checked at every follow-up (typically every 3–6 months). If it rises above 52–54%, the physician can:

• Reduce the testosterone dose
• Switch to a more frequent, lower-dose injection protocol (which reduces peak-to-trough fluctuations)
• Switch to a topical gel or cream formulation
• Recommend therapeutic phlebotomy (blood donation) — which is simple, safe, and immediately effective

The bottom line: Polycythemia is a real side effect that requires monitoring. It is not dangerous when caught and managed appropriately – which is exactly what routine blood work ensures. Men living at high altitude – such as Bogotá (2,640 m) – have naturally higher hematocrit baselines, making altitude-adjusted monitoring especially important.

2. Fertility Suppression

The concern: Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis through negative feedback. When the brain detects adequate testosterone from an external source, it reduces the signals (LH and FSH) that tell the testes to produce both testosterone and sperm. This can cause:

• Reduced sperm count (oligospermia)
• Complete absence of sperm (azoospermia)
• Testicular atrophy (smaller testes from disuse)

How common: Very common. According to the Endocrine Society’s 2018 Clinical Practice Guidelines, TRT is explicitly contraindicated in men who are currently trying to conceive. The effect on sperm production occurs in the majority of men on TRT, though the degree varies.

Is it reversible? In most cases, yes – but recovery takes time. Studies show that sperm production typically returns within 6–12 months after discontinuing TRT, though some men may require longer, and a small percentage may experience prolonged or permanent suppression, particularly those with pre-existing fertility issues.

Alternatives for men wanting children: Physicians can use alternatives such as clomiphene citrate (an off-label SERM that stimulates the body’s own testosterone production without suppressing fertility) or human chorionic gonadotropin (hCG) to maintain testicular function during TRT.

The bottom line: This is a serious consideration – not a trivial side effect. But it is entirely manageable with proper planning. If you are considering TRT and want children in the future, discuss this with your physician before starting treatment. This is part of the comprehensive evaluation process at TRT Optima.

3. Acne and Oily Skin

The concern: Testosterone and its metabolite dihydrotestosterone (DHT) stimulate sebaceous gland activity, increasing sebum production. This can lead to acne – particularly on the back, shoulders, and face.

How common: Mild to moderate acne affects a notable percentage of TRT patients, especially during the first few months of treatment when hormone levels are adjusting. Severe acne is relatively uncommon with physiological replacement doses.

How it is managed: In most cases, acne resolves or improves as hormone levels stabilize. Standard dermatological approaches – proper skincare, topical treatments, and in persistent cases, prescription medications – are effective. Dose adjustments or changes to injection frequency can also help by reducing hormonal fluctuations.

The bottom line: Annoying but manageable. Not a medical reason to avoid TRT if you need it.

4. Fluid Retention and Edema

The concern: Testosterone can promote sodium and water retention, leading to temporary swelling — particularly in the ankles, feet, and hands. Some patients also notice elevated blood pressure during the initial weeks of treatment.

How common: Mild fluid retention is fairly common in the first 4–8 weeks of TRT. Clinically significant edema is uncommon at physiological replacement doses.

How it is managed: Fluid retention typically resolves on its own as the body adapts. Monitoring blood pressure, maintaining adequate hydration, moderating sodium intake, and in rare cases, adjusting the dose can help. Patients with pre-existing heart failure or kidney disease require closer monitoring.

The bottom line: Temporary, usually self-resolving. Requires attention in patients with cardiovascular or renal comorbidities.

5. Changes in Cholesterol and Lipid Profile

The concern: Some studies have shown that TRT can reduce HDL (“good”) cholesterol, particularly with oral testosterone preparations and supraphysiological doses. Changes to LDL and triglycerides are more variable.

What the evidence says: A meta-analysis by Corona et al. (2016) found that testosterone therapy’s effects on lipid profiles were generally modest at physiological replacement doses, with the most significant HDL reductions seen with oral formulations (which are rarely used in modern TRT protocols). Injectable and transdermal testosterone had minimal clinically significant lipid effects in most men.

How it is managed: Lipid panels are included in standard monitoring blood work. Lifestyle factors — diet, exercise, and metabolic health management – play a much larger role in cardiovascular lipid risk than TRT itself.

The bottom line: A consideration, not a crisis. Regular monitoring handles it.

6. Sleep Apnea Worsening

The concern: Testosterone may worsen obstructive sleep apnea (OSA) in men who already have the condition, though the mechanism is not fully understood. The Endocrine Society guidelines list severe untreated OSA as a relative contraindication for TRT.

How common: The evidence here is mixed. Some studies suggest an association; others find no clinically significant worsening. What is clear is that men with untreated, severe sleep apnea should address it before or concurrently with starting TRT.

The bottom line: If you have sleep apnea, it should be treated — regardless of whether you start TRT. If you notice increased snoring, daytime sleepiness, or worsening sleep quality on treatment, let your physician know. Our guide on the connection between sleep, stress, and hormonal health explains why sleep quality is foundational to any hormone protocol.

→ Questions about TRT safety? Schedule your evaluation with a physician who monitors properly.

Exaggerated Fears: Side Effects That Are Misunderstood or Overstated

Now for the concerns that dominate online forums but do not hold up under scrutiny — or are far more nuanced than the headlines suggest.

“TRT Causes Heart Attacks”

This was the dominant narrative from 2013 to 2023, fueled by two observational studies with serious methodological limitations. As discussed above, the TRAVERSE trial (2023) – a prospective, randomized, controlled trial designed specifically to answer this question – found no increased cardiovascular risk. In fact, a 2017 meta-analysis published in The Lancet Diabetes & Endocrinology by Alexander et al. had already suggested that the cardiovascular risk from TRT was not supported by the totality of evidence.

Does this mean TRT is cardiovascular-risk-free? No. Men with pre-existing cardiovascular disease should be monitored closely. But the idea that TRT itself causes heart attacks has been essentially refuted by the strongest evidence available.

“TRT Causes Prostate Cancer”

This fear dates back to 1941, when Charles Huggins demonstrated that castration (removing testosterone) caused prostate cancer regression. The logical leap – that adding testosterone must cause prostate cancer, persisted for decades without strong supporting evidence.

Modern data tells a different story. The TRAVERSE trial included prostate safety as a secondary endpoint and found no increase in prostate cancer incidence in the testosterone-treated group. A 2015 meta-analysis by Boyle et al. in European Urology similarly concluded that testosterone therapy does not increase the risk of prostate cancer.

The Endocrine Society guidelines recommend PSA monitoring during TRT and caution against initiating therapy in men with untreated prostate cancer – but they explicitly state that a history of successfully treated prostate cancer is not an absolute contraindication, and that the evidence does not support a causal link between TRT and prostate cancer development.

The responsible approach: Monitor PSA at baseline and every 6–12 months. Investigate significant changes. But fear of prostate cancer alone should not prevent a man with confirmed hypogonadism from receiving treatment.

“TRT Causes ‘Roid Rage’ or Aggression”

This one conflates TRT with anabolic steroid abuse. Supraphysiological doses of testosterone, the kind used in bodybuilding (often 500–2,000+ mg/week) – can indeed affect mood, impulse control, and aggression. But TRT uses physiological replacement doses (typically 100–200 mg/week for injectable testosterone) designed to restore levels to the normal range, not exceed them.

Research consistently shows that restoring testosterone to normal levels actually improves mood, reduces irritability, and enhances emotional stability. A study by Cherrier et al. (2001) demonstrated cognitive and mood improvements at physiological testosterone levels. Many men experience relief from brain fog and mood disturbances after starting properly dosed TRT.

If anything, low testosterone is more strongly associated with irritability, anxiety, and depression than optimized testosterone is with aggression.

“TRT Causes Liver Damage”

This concern applies specifically to oral methyltestosterone — a formulation that passes through the liver and is known to be hepatotoxic. This form is rarely prescribed in modern clinical practice and is not used at reputable clinics.

Injectable testosterone (cypionate, enanthate) and transdermal formulations bypass the liver entirely. There is no evidence linking these standard delivery methods to liver damage.

How Monitoring Prevents Most Problems

The single biggest factor separating safe TRT from risky TRT is not the testosterone itself — it is the quality of medical oversight. The vast majority of side effects are either preventable or manageable through proper monitoring.

The Standard Monitoring Protocol

Based on the Morgentaler et al. (2016) consensus guidelines, a responsible TRT monitoring protocol includes:

Marker	When Checked	Why It Matters
Total & Free Testosterone	Baseline, 3 months, then every 6–12 months	Confirms treatment is achieving target levels
Estradiol (E2)	Every blood draw	Monitors testosterone-to-estradiol balance
Hematocrit / CBC	Baseline, 3 months, then every 6–12 months	Detects polycythemia early
PSA	Baseline, 3–6 months, then annually	Prostate health screening
Lipid Panel	Baseline, 6 months, then annually	Cardiovascular risk assessment
Liver Function (AST/ALT)	Baseline, periodically	Baseline safety marker
Blood Pressure	Every visit	Fluid retention and cardiovascular monitoring
LH & FSH	Baseline (pre-treatment)	Establishes baseline pituitary function

This is the monitoring standard at TRT Optima. It is also why choosing a clinic that takes monitoring seriously, rather than a clinic that simply prescribes and disappears – is the most important decision you make. If you are in Colombia, our guide on how to get tested walks through the practical steps and costs.

When Side Effects Mean Something Is Wrong

Not all side effects are “expected and manageable.” Certain symptoms on TRT warrant immediate medical attention:

• Chest pain, shortness of breath, or leg swelling — Could indicate a thromboembolic event. Seek emergency care.
• Severe headaches or vision changes — May suggest elevated hematocrit or blood pressure.
• Breast tenderness or gynecomastia — May indicate elevated estradiol relative to testosterone. Blood work should be drawn and the protocol adjusted. Our article on testosterone levels and the T:E2 ratio explains why this balance matters.
• Significant mood changes — If you experience anxiety, depression, or emotional instability after starting TRT, your dose may be too high, your estradiol may be out of balance, or the formulation may not suit you.
• Urinary symptoms — Difficulty urinating, frequent urination, or weak stream can indicate prostate issues and should be evaluated promptly.

The message is simple: side effects are information. When communicated to your physician, they guide adjustments that keep you safe. When ignored or hidden, they can become genuine problems.

The Risk of Not Treating: The Side Effects Nobody Talks About

The conversation about TRT side effects almost always focuses on the risks of treatment. Rarely does anyone discuss the risks of not treating confirmed hypogonadism.

Untreated low testosterone is associated with:

• Increased cardiovascular risk — A study by Araujo et al. (2007) found that low testosterone independently predicted increased mortality risk in men.
• Chronic fatigue and reduced quality of life — Persistent low energy that affects work, relationships, and daily function.
• Metabolic syndrome and type 2 diabetes — Low testosterone is both a risk factor for and a consequence of metabolic dysfunction, creating a worsening cycle.
• Osteoporosis and fracture risk — Testosterone (and its conversion to estradiol) is critical for bone mineral density in men.
• Depression and cognitive decline — Multiple studies link untreated hypogonadism to increased rates of depression and cognitive dysfunction.
• Sexual dysfunction — Progressive loss of libido and erectile function.

The question is not “does TRT have risks?” — every medical intervention does. The question is: do the risks of treatment outweigh the risks of living with untreated hormonal deficiency? For most men with confirmed hypogonadism and proper monitoring, the evidence firmly supports treatment.

How to Minimize TRT Side Effects: Practical Guidance

Most side effects are dose-dependent, protocol-dependent, or lifestyle-influenced. Here is what you can do:

1. Choose the right clinic. The quality of your medical supervision matters more than anything else. A clinic that monitors blood work every 3–6 months, adjusts protocols based on data, and communicates transparently about risks will prevent most problems. Learn about what to expect from TRT in Colombia and what it costs.
2. Follow the protocol. Do not self-adjust doses, skip blood work, or stop treatment without consulting your physician. Abrupt discontinuation can cause a hormonal crash that is worse than the original deficiency.
3. Optimize your lifestyle alongside treatment. TRT is not a replacement for healthy habits. Sleep, exercise, nutrition, and stress management all influence how your body responds to testosterone and how effectively it manages estradiol conversion. Our article on science-backed ways to boost testosterone naturally covers the lifestyle factors that matter most.
4. Stay hydrated and monitor blood pressure. Simple measures that help with fluid retention and cardiovascular health.
5. Communicate with your physician. If something feels wrong — even if you cannot articulate exactly what — report it. Side effects caught early are far easier to manage.

→ Ready for TRT done safely? Schedule your comprehensive evaluation with TRT Optima.

Frequently Asked Questions

What is the most common side effect of TRT?

Polycythemia — an increase in red blood cell count — is the most commonly observed laboratory side effect. It is detected through routine blood work and managed by adjusting the dose, injection frequency, or delivery method. It is not dangerous when monitored properly.

Does TRT increase your risk of a heart attack?

The TRAVERSE trial (2023), the largest controlled study on TRT safety, found no increased risk of major cardiovascular events in men taking testosterone — even those with pre-existing cardiovascular risk factors. The earlier studies that suggested a link had significant methodological limitations.

Can TRT cause prostate cancer?

Current evidence does not support a causal relationship between testosterone replacement therapy and prostate cancer. The Endocrine Society recommends PSA monitoring during treatment but does not consider physiological TRT a prostate cancer risk factor. Men with a history of successfully treated prostate cancer should discuss their individual risk with their physician.

Will TRT make me infertile?

TRT suppresses sperm production in most men while they are on treatment. This effect is usually reversible after discontinuation, though recovery can take 6–12 months. Men who want to preserve fertility have alternative treatment options, including clomiphene citrate and hCG, which should be discussed before starting TRT.

Does TRT cause hair loss?

TRT may accelerate male pattern baldness in men who are genetically predisposed. It does not cause hair loss in men without the genetic susceptibility. If hair loss is a concern, your physician can monitor for changes and discuss preventive strategies.

Is it safe to take TRT long-term?

Long-term TRT is well-supported by evidence when monitored appropriately. Many men with primary hypogonadism require indefinite treatment. The key to long-term safety is consistent medical oversight, regular blood work, and protocol adjustments based on your evolving health data.

What happens if I stop TRT suddenly?

Abruptly stopping TRT can cause a temporary but significant hormonal crash — fatigue, mood disturbances, loss of libido, and other symptoms of low testosterone. If discontinuation is necessary, it should be done gradually under medical supervision, potentially with transitional medications to help restart natural production.

The Bottom Line

TRT side effects are real — but they are not the boogeyman the internet makes them. The vast majority are manageable, monitorable, and preventable with proper medical oversight. The truly dangerous scenario is not receiving TRT with professional supervision — it is receiving it without it, or avoiding treatment entirely when your body clearly needs it.

The data is now clearer than it has ever been: the TRAVERSE trial resolved the cardiovascular question. Modern monitoring protocols catch polycythemia, lipid changes, and prostate issues early. Fertility can be preserved with proper planning. And the risks of untreated hypogonadism — cardiovascular, metabolic, psychological — are well-documented and growing.

The right question is not “does TRT have side effects?” It is: “is the clinic monitoring me well enough to manage them?”

At TRT Optima, every protocol begins with comprehensive diagnostics, continues with regular monitoring, and adapts based on your blood work — not guesswork. Because safe TRT is not about avoiding treatment. It is about doing it right.

Schedule Your Free Medical Evaluation with TRT Optima →